Security key
23285D109
Cytek Biosciences, Inc. - Common Stock (CTKB)
CUSIP: 23285D109
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 76,158,342
- Total 13F value
- $424,969,676
- Share change
- -4,438,435
- Put/Call ratio
- 50%
- SEC-reported price per share
- $5.58
- Number of holders
- 126
- Value change
- -$33,289,478
- Number of buys
- 73
- Number of sells
- 54
- Shares outstanding
- 129,952,097
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
126
Top holders
10
CTKB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Cytek Biosciences, Inc. SEC filings
Cytek Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23285D109
Recent filing periods:
Ownership snapshot
Top reported holders of CTKB - Cytek Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
13%
BROWN CAPITAL MANAGEMENT LLC
9.3%
VANGUARD GROUP INC
9.2%
RA CAPITAL MANAGEMENT, L.P.
5.2%
HHLR ADVISORS, LTD.
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
13%
|
$116,928,265
17,425,971 shares
|
— | 31 Mar 2024 |
| BROWN CAPITAL MANAGEMENT LLC |
13F
Company
|
9.3%
|
$80,667,714
12,022,014 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.2%
|
$80,605,921
12,012,805 shares
|
— | 31 Mar 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
13F
Director, 10%+ Owner · Company
|
5.2%
from 13F
|
$127,120,013
13,381,054 shares
|
— | 14 Mar 2022 |
| HHLR ADVISORS, LTD. |
13F
Company
|
5.1%
|
$44,668,671
6,657,030 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
3.2%
|
$27,617,414
4,115,859 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
126
Shares
76,158,342
Rows available
126
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
119
Q2 2024 holders
126
Holder diff
7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend